IL10 and diabetes mellitus: A significantly higher concentration of IL-10 in the plasma of patients with newly diagnosed diabetes compared to patients treated chronically and the control group suggests an attempt to activate regulatory mechanisms in patients’ cases at an early stage of the disease, which do not constitute protection against the progressive progression of the disease.